Увійти

Готові списки джерел за темами / Non-Alcoholic fatty liver diseases / Книги

Книги з теми "Non-Alcoholic fatty liver diseases"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Non-Alcoholic fatty liver diseases.

Автор: Grafiati

Опубліковано: 22 червня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-44 книг для дослідження на тему "Non-Alcoholic fatty liver diseases".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Bugianesi, Elisabetta, ed. Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-95828-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Farrell, Geoffrey C., Arthur J. McCullough, and Christopher P. Day, eds. Non-Alcoholic Fatty Liver Disease. Oxford, UK: Wiley-Blackwell, 2013. http://dx.doi.org/10.1002/9781118556153.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Chalasani, Naga, and Gyongyi Szabo, eds. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20538-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Taylor-Robinson, Simon D., and Roger Williams. Clinical dilemmas in non-alcoholic fatty liver disease. Chichester, West Sussex: John Wiley & Sons Inc., 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Farrell, Geoffrey C., Arthur J. McCullough, and Christopher Paul Day. Non-alcoholic fatty liver disease: A practical guide. Chichester, West Sussex: John Wiley & Sons, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Williams, Roger, and Simon D. Taylor-Robinson, eds. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118924938.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Buko, V. U. Prostaglandiny pri alkogolʹnom porazhenii pecheni. Minsk: "Navuka i tėkhnika", 1991.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Fitzpatrick, Emer. Non-alcoholic fatty liver disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0061.

Повний текст джерела

Анотація:

The chapter on non-alcoholic fatty liver disease includes the risk factors for this ever-increasing condition, the pathophysiology, as well as the differential of hepatic steatosis. Finally it includes the most current principles of its management.

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Khanna, Sudeep. Non-Alcoholic Fatty Liver Disease. Elsevier - Health Sciences Division, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Chalasani, Naga, and Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside. Springer, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Chalasani, Naga, and Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside. Springer London, Limited, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Chalasani, Naga, and Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside. Springer, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Wiley & Sons, Limited, John, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Wiley & Sons, Incorporated, John, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Wiley & Sons, Incorporated, John, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Day, Christopher P., Geoffrey C. Farrell, and Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley & Sons, Incorporated, John, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Day, Christopher P., Geoffrey C. Farrell, and Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley & Sons, Incorporated, John, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Day, Christopher P., Geoffrey C. Farrell, and Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley & Sons, Incorporated, John, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Day, Christopher P., Geoffrey C. Farrell, and Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley & Sons, Limited, John, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Pearce, Pearson. Non-Alcoholic Fatty Liver Disease: All You Must Know about Non-Alcoholic Fatty Liver Disease. Independently Published, 2021.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Non-Alcoholic Fatty Liver Disease Research 2016. MDPI, 2018. http://dx.doi.org/10.3390/books978-3-03897-601-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

OGAGAOGHENE, Isreal. Non Alcoholic Fatty Liver Disease: All You Must Know. Independently Published, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Bugianesi, Elisabetta. Non-Alcoholic Fatty Liver Disease: A 360-degree Overview. Springer, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Gaglio, Paul J. Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease. Elsevier, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Gaglio, Paul J. Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease. Elsevier - Health Sciences Division, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Beattie, R. Mark, Anil Dhawan, and John W.L. Puntis. Fatty liver disease in children. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0055.

Повний текст джерела

Анотація:

Demographics 406Pathophysiology 406Differential diagnoses 407Presenting features 407Investigation 408Management 409Fatty liver disease is now increasingly recognized in children, particularly in the setting of obesity.The term non-alcoholic steatohepatitis (NASH) was first coined in 1980 by Ludwig to describe a pattern of liver injury in adults in which the liver histology was consistent with alcoholic hepatitis, but in whom significant alcohol consumption was denied. NASH can be considered as part of a broader spectrum of non-alcoholic fatty liver disease that extends from simple steatosis through steatohepatitis that is characterized by the potential to progress to fibrosis, cirrhosis and subsequent end stage liver disease....

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Valenzuela, Rodrigo, ed. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. InTech, 2018. http://dx.doi.org/10.5772/68045.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Keshav, Satish, and Palak Trivedi. Miscellaneous liver diseases. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0216.

Повний текст джерела

Анотація:

This chapter discusses miscellaneous liver diseases, including non-alcoholic fatty liver disease, liver abscess, and nodular regenerative hyperplasia. It explores definitions of the diseases, their etiologies, typical symptoms, uncommon symptoms, demographics, natural history, complications, diagnostic approach, other diagnoses that should be considered, prognosis, and treatment.

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Keshav, Satish, and Alexandra Kent. Alcoholic liver disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0211.

Повний текст джерела

Анотація:

Alcoholic liver disease develops in excessive drinkers and can manifest in three forms: alcoholic fatty liver (steatosis; >80%), alcoholic hepatitis (10%–35%), and cirrhosis (10%). The more alcohol consumed, the greater the risk of alcoholic liver disease, although other factors may also be involved. Alcohol can cause significant damage without producing any symptoms, and many patients will only have liver dysfunction detected on routine blood tests. Many patients report non-specific symptoms, such as anorexia, morning nausea, diarrhoea, and vague right upper quadrant abdominal pain. The underlying pathogenesis of alcohol-induced injury is not fully understood but is thought to involve various mechanisms. This chapter discusses alcoholic liver disease, focusing on its etiology, symptoms, demographics, natural history, complications, diagnosis, prognosis, and treatment.

Стилі APA, Harvard, Vancouver, ISO та ін.

30

McNiff, Pil, and Diana Jo Rossano. Non Alcoholic Fatty Liver Disease: Recipes That Improve NASH, NAFLD, and Silent Liver Disease. Independently Published, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Bergheim, Ina, and Jörn M. Schattenberg. Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease. Mdpi AG, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Avand, Ghazal. Metabolic syndrome in non-alcoholic fatty liver disease: A comparison between simple steatosis and non-alcoholic steatohepatitis. 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Nutritional Intake and the Risk for Non-alcoholic Fatty Liver Disease (NAFLD). MDPI, 2019. http://dx.doi.org/10.3390/books978-3-03897-599-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Non-alcoholic Fatty Liver Disease - New-Insight and Glance Into Disease Pathogenesis [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.100998.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Mohammed, Saira Saddia. Obesity is not associated with non-alcoholic fatty liver disease (NAFLD) in HIV-positive gay males. 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Mancell, Sara, and Deepa Kamat. Nutritional management of liver disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0068.

Повний текст джерела

Анотація:

The chapter on nutrition and liver disease describes the pathophysiology of the malnutrition that frequently accompanies chronic liver disease in children and then discusses the suggested management as well as ways of nutritional assessment and monitoring of the children. There is also a section of specific suggestions for various conditions such as biliary atresia, Alagille syndrome, Wilson disease, non-alcoholic fatty liver disease, as well as an overview of the various special feeds and supplements used in these conditions.

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Carton, James. Hepatobiliary pathology. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198759584.003.0008.

Повний текст джерела

Анотація:

This chapter discusses hepatobiliary pathology and covers acute viral hepatitis, chronic viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), Wilson’s disease, hereditary haemochromatosis, cirrhosis, benign liver lesions, hepatocellular carcinoma (liver cell cancer), intrahepatic cholangiocarcinoma, cholecystitis, and extrahepatic bile duct carcinoma.

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Jolly, Elaine, Andrew Fry, and Afzal Chaudhry, eds. Gastroenterology and hepatology. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199230457.003.0009.

Повний текст джерела

Анотація:

Chapter 9 covers the basic science and clinical topics relating to gastroenterology and hepatology which trainees are required to learn as part of their basic training and demonstrate in the MRCP. It covers basic science, gastrointestinal investigation, malabsorption and malnutrition, inflammatory bowel disease, acute upper gastrointestinal haemorrhage, lower gastrointestinal bleeding and related disorders, gastrointestinal infections, gastrointestinal cancer, miscellaneous gastrointestinal problems, normal liver and biliary function, variceal disease, hepatic tumours, acute (fulminant) liver failure, haemochromatosis, Wilson disease (hepatolenticular degeneration), Alpha-1 antitrypsin deficiency, alcohol-induced liver disease, hepatitis, biliary diseases, and non-alcoholic fatty liver disease.

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Keshav, Satish, and Alexandra Kent. Prevention of gastrointestinal disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0346.

Повний текст джерела

Анотація:

Disease prevention is usually directed where there is considerable morbidity or mortality, and etiological factors that can be controlled, treated, or reduced. The greatest morbidity and mortality from gastrointestinal disease is related to infectious diarrhoea and gastrointestinal cancer, both of which can be prevented. Smoking has been closely associated with oesophageal, gastric, and liver cancer and also has a significant effect in inflammatory bowel disease. In addition, alcohol consumption and viral hepatitis are preventable causes of liver disease, liver failure, and hepatic cancer. This chapter addresses the prevention of gastrointestinal disease, focusing on alcohol, smoking, peptic ulcer disease, colorectal cancer, oesophageal adenocarcinoma, hepatitis B, hepatitis C, non-alcoholic fatty liver disease, and gastrointestinal infection.

Стилі APA, Harvard, Vancouver, ISO та ін.

40

CHRIS, John. Fatty Liver Rescue: Comprehensive Cure of Non-Alcoholic Fatty Liver for Beginners. Independently Published, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Plebani, Mario, Monica Maria Mion, and Martina Zaninotto. Biomarkers of renal and hepatic failure. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0039.

Повний текст джерела

Анотація:

In the last few years, major advances have been achieved in the understanding of the molecular and pathophysiological mechanisms which underlie the complex interactions between the heart and the kidney, as well as between the heart and the liver. According to these new insights, new biomarkers have been proposed for better evaluating and monitoring patients affected by cardiovascular diseases. In addition, some biomarkers should be used as risk factors and for an early identification and treatment of these severe diseases. This chapter reviews the most important biomarkers for evaluating the ‘cardiorenal syndrome’, in particular, the measurement of serum creatinine and its use for calculating the glomerular filtration rate which, with the new and more efficient equation, namely Chronic Kidney Disease Epidemiology Collaboration, still remains the most widely used biomarker. The role of newer biomarkers will be explored. The measurement of cystatin C, representing additional information, particularly in paediatric age groups and in the early phase of kidney disease, plays an increasing role. Neutrophil gelatinase-associated lipocalin is a recently developed and very promising new biomarker for the diagnosis of acute kidney injury, while the well-known albumin/creatinine ratio has been re-evaluated as a simple and useful tool for an early identification of kidney disease. Regarding liver diseases, a growing body of evidence demonstrates the usefulness of non-invasive makers of hepatic fibrosis that may avoid the need for a liver biopsy in most patients. A promising field of research is represented by the role of non-alcoholic fatty liver disease in the pathogenesis of cardiovascular disease.

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Carton, James. Hepatobiliary pathology. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199591633.003.0007.

Повний текст джерела

Анотація:

Acute viral hepatitis 116Chronic viral hepatitis 117Alcoholic liver disease 118Non-alcoholic fatty liver disease 119Autoimmune hepatitis 120Primary biliary cirrhosis 121Primary sclerosing cholangitis 122Wilson's disease 123Hereditary haemochromatosis 124Cirrhosis 125Benign liver lesions 126Hepatocellular carcinoma 127Intrahepatic cholangiocarcinoma ...

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Harrison, Stephen A. Non-Alcoholic Steatohepatitis, an Issue of Clinics in Liver Disease. Elsevier - Health Sciences Division, 2009.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Levy, Barry S. Liver Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662677.003.0030.

Повний текст джерела

Анотація:

This chapter describes occupational and environmental liver disorders. It describes the types of liver function and types of liver damage, and how these functions and this damage can be assessed. Workers in healthcare and solid waste management are at increased risk hepatitis B virus and hepatitis C virus infections. Occupational exposure to swine is associated with hepatitis E virus infection. More than 100 industrial chemicals can be acutely hepatotoxic in experimental animals or humans. Metabolic reactions may affect the hepatotoxicity of chemicals. Occupational exposure to organic solvents can cause toxic hepatitis. Occupational exposure to vinyl chloride monomer has been causally associated with toxicant-associated fatty liver disease as well as a form of non-cirrhotic portal hypertension. Several agents can cause cancer of the liver or bile ducts. Vinyl chloride monomer is causally associated with angiosacoma of the liver. Arsenic causes liver cancer. Dietary exposure to aflatoxins can cause hepatoceulluar carcinoma.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!